Abstract
Clinicians are advised caution in reducing serum urate for gout management due to observational associations with risk of neuropsychiatric diseases. We examined the causal effect of genetically predicted serum urate levels on the risk of major depressive disorder (MDD), anxiety, and related psychiatric disorders using two-sample Mendelian randomization (MR). We identified single-nucleotide polymorphisms (SNPs) associated with serum urate from a genome-wide association study (GWAS) of 110,347 European-descent individuals. The causal effect of serum urate on MDD was tested using summary data from a GWAS of 135,458 cases and 344,901 controls of European descent. MR was performed using random-effects inverse variance-weighted method and a series of sensitivity analyses. This approach was repeated using summary GWAS data for anxiety, bipolar disorder, post-traumatic stress disorder, obsessive-compulsive disorder, attention-deficit/hyperactivity disorder, schizophrenia, and anorexia nervosa. We identified 30 SNPs associated with serum urate. Genetically predicted urate levels were not causally associated with risk of MDD (OR 0.98; 95% CI 0.94, 1.03), anxiety (OR 0.90; 95% CI 0.80, 1.02), or the other psychiatric conditions (OR range 0.95 to 1.06). Results were similar in sensitivity analyses. We found no evidence that genetically predicted serum urate has a causal effect on risk of MDD, anxiety, or other psychiatric disorders.
Key Points • Clinicians are advised to be cautious about reducing the serum urate level too far in gout management, citing observational associations between low serum urate levels and various neuropsychiatric diseases. • In this two-sample Mendelian randomization study, we found no evidence for a causal link between genetically predicted serum urate level and the development of major depressive, anxiety, or other related psychiatric disorders. • Future revisions of clinical guidelines may need to reconsider recommendations regarding lower limits for serum urate levels. |
Data availability
All summary GWAS data are publicly available from the respective authors; details are provided in supplementary materials.
References
Dalbeth N, Choi HK, Joosten LAB, Khanna PP, Matsuo H, Perez-Ruiz F et al (2019) Gout. Nature reviews Disease primers 5(1):69
Howren A, Bowie D, Choi HK, Rai SK, De Vera MA (2020) Epidemiology of depression and anxiety in gout: a systematic review and metaanalysis. J Rheumatol
Richette P, Doherty M, Pascual E, Barskova V, Becce F, Castaneda-Sanabria J et al (2017) 2016 updated EULAR evidence-based recommendations for the management of gout. Annals of the rheumatic diseases. 76(1):29–42
Hui M, Carr A, Cameron S, Davenport G, Doherty M, Forrester H, Jenkins W, Jordan KM, Mallen CD, McDonald TM, Nuki G, Pywell A, Zhang W, Roddy E, for the British Society for Rheumatology Standards, Audit and Guidelines Working Group (2017) The British Society for Rheumatology guideline for the management of gout. Rheumatology. 56(7):1246
Euser SM, Hofman A, Westendorp RG, Breteler MM (2009) Serum uric acid and cognitive function and dementia. Brain : a journal of neurology. 132(Pt 2):377–382
Bartoli F, Trotta G, Crocamo C, Malerba MR, Clerici M, Carra G (2018) Antioxidant uric acid in treated and untreated subjects with major depressive disorder: a meta-analysis and meta-regression. European archives of psychiatry and clinical neuroscience. 268(2):119–127
Wen M, Zhou B, Chen YH, Ma ZL, Gou Y, Zhang CL, Yu WF, Jiao L (2017) Serum uric acid levels in patients with Parkinson’s disease: a meta-analysis. PloS one. 12(3):e0173731
Waring WS, Webb DJ, Maxwell SR (2001) Systemic uric acid administration increases serum antioxidant capacity in healthy volunteers. Journal of cardiovascular pharmacology. 38(3):365–371
Maxwell MA, Cole DA (2009) Weight change and appetite disturbance as symptoms of adolescent depression: toward an integrative biopsychosocial model. Clinical psychology review. 29(3):260–273
Davies NM, Holmes MV, Davey SG (2018) Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. Bmj. 362:k601
Kottgen A, Albrecht E, Teumer A, Vitart V, Krumsiek J, Hundertmark C et al (2013) Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nature genetics. 45(2):145–154
Burgess S, Butterworth A, Thompson SG (2013 Nov) Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 37(7):658–665
Bowden J, Davey Smith G, Burgess S (2015) Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. International journal of epidemiology. 44(2):512–525
Verbanck M, Chen CY, Neale B, Do R (2018) Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 50(5):693–698
Bowden J, Davey Smith G, Haycock PC, Burgess S (2016) Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. 40(4):304–314
Liu T, Zhong S, Liao X, Chen J, He T, Lai S, Jia Y (2015) A meta-analysis of oxidative stress markers in depression. PloS one. 10(10):e0138904
Lyngdoh T, Bochud M, Glaus J, Castelao E, Waeber G, Vollenweider P, Preisig M (2013) Associations of serum uric acid and SLC2A9 variant with depressive and anxiety disorders: a population-based study. PloS one. 8(10):e76336
Yuan H, Yang W (2018) Genetically determined serum uric acid and Alzheimer’s disease risk. J Alzheimers Dis. 65(4):1259–1265
Kia DA, Noyce AJ, White J, Speed D, Nicolas A, collaborators I et al (2018) Mendelian randomization study shows no causal relationship between circulating urate levels and Parkinson’s disease. Ann Neurol. 84(2):191–199
Smith GD, Ebrahim S (2003) ‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 32(1):1–22
Code availability
Not applicable.
Funding
YM is supported by grants from National Natural Science Foundation of China (81973663 and 81873269), and the talent project of Zhejiang Association for Science and Technology (2018YCGC003).
Author information
Authors and Affiliations
Contributions
All authors contributed to the manuscript and approved its submission.
Corresponding author
Ethics declarations
Ethics approval
Not applicable.
Conflict of interest
SLM: Consultancy on behalf of institution to: Roche/Chugai, Sanofi. Investigator on industry-sponsored clinical trials for: GSK, Sanofi. Attendance at EULAR2019 supported by Roche. Co-applicant on research grants from Vifor and Roche. Patron of the charity PMRGCAuk. This publication presents independent research supported by the Leeds Biomedical Research Centre. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. The other authors have disclosed no conflicts of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
ESM 1
(DOCX 59 kb)
Rights and permissions
About this article
Cite this article
Zhao, S.S., Qian, Y., Mackie, S.L. et al. Genetically predicted serum urate levels have no causal role on depression or other psychiatric disorders. Clin Rheumatol 40, 3729–3733 (2021). https://doi.org/10.1007/s10067-021-05718-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-021-05718-3